In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The 4G/5G PAI-1 polymorphism influences the endothelial response to IL-1 and the modulatory effect of pravastatin
    Roncal, C.
    Orbe, J.
    Belzunce, M.
    Rodriguez, J. A.
    Paramo, J. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (08) : 1798 - 1803
  • [42] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Yildirim, Malik Ejder
    Karakus, Savas
    Kurtulgan, Hande Kucuk
    Kilicgun, Hasan
    Ersan, Serpil
    Bakir, Sevtap
    BIOCHEMICAL GENETICS, 2017, 55 (04) : 314 - 321
  • [43] The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels
    Sari, Esin Sogutlu
    Yazici, Alper
    Eser, Betul
    Erol, Muhammet Kazim
    Kilic, Adil
    Ermis, Sitki Samet
    Koytak, Arif
    Aksit, Hasan
    Yakut, Tahsin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2014, 33 (04) : 270 - 274
  • [44] 4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: A prospective study
    Burzotta, F
    Iacoviello, L
    Di Castelnuovo, A
    Zamparelli, R
    D'Orazio, A
    Amore, C
    Schiavello, R
    Donati, MB
    Maseri, A
    Possati, G
    Andreotti, F
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2003, 16 (03) : 149 - 154
  • [45] Bilateral pulmonary embolism in twins with PAI-1 4G/5G gene polymorphism: a case reportZwillinge mit bilateraler Pulmonalembolie und PAI-1 4G/5G Genpolymorphismus: Ein Fallbericht
    Andreas Kronbichler
    Peter Oelzner
    Günter Syrbe
    Eric Lopatta
    Gunter Wolf
    Thomas Neumann
    Wiener klinische Wochenschrift, 2014, 126 : 53 - 55
  • [46] 4G/5G PAI-1 Promoter Polymorphism and Acute-Phase Levels of PAI-1 Following Coronary Bypass Surgery: A Prospective Study
    Francesco Burzotta
    Licia Iacoviello
    Augusto Di Castelnuovo
    Roberto Zamparelli
    Andria D'Orazio
    Concetta Amore
    Rocco Schiavello
    Maria Benedetta Donati
    Attilio Maseri
    GianFederico Possati
    Felicita Andreotti
    Journal of Thrombosis and Thrombolysis, 2003, 16 : 149 - 154
  • [47] THE ASSOCIATION BETWEEN CIRCULATING PLASNUNOGEN ACTIVATOR INHIBITOR TYPE 1 (PAI-1 LEVELS, THE PAI-1 4G/5G POLYMORPHISM AND INCIDENT MYOCARDIAL INFRACTION
    Tsangaris, I.
    Tsaknis, G.
    Nikolopoulos, G.
    Bonovas, S.
    Bagos, P.
    Tsantes, A.
    Kopterides, P.
    Vrigkou, E.
    Konstantonis, D.
    Armaganidis, A.
    INTENSIVE CARE MEDICINE, 2013, 39 : S245 - S246
  • [48] The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer
    Malik Ejder Yıldırım
    Savas Karakuş
    Hande Küçük Kurtulgan
    Hasan Kılıçgün
    Serpil Erşan
    Sevtap Bakır
    Biochemical Genetics, 2017, 55 : 314 - 321
  • [49] 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) influences the relationship between C-reactive protein and PAI-1 in type 2 diabetic patients
    Testa, I.
    Bonfigli, A. R.
    Marra, M.
    Boemi, M.
    Sirolla, C.
    Mari, D.
    Sacchi, E.
    Dolci, A.
    Catalano, A.
    Procopio, A.
    Ceriello, A.
    Testa, R.
    DIABETOLOGIA, 2006, 49 : 220 - 220
  • [50] PAI-1 4G/5G polymorphism in a cohort of patients with thrombosis and antiphospholipid antibodies (APA)
    Bellia, M.
    Apergis, G.
    Gafou, A.
    Sklavou, S.
    Pavlou, E.
    Papadopoulou, V.
    Theodosiades, G.
    Andrioti, E.
    BLOOD REVIEWS, 2007, 21 : S100 - S100